Matthew Old

Also affiliated with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Not So Fast: Deintensification Therapy for Locally Advanced Oral Cavity Cancer”.

Not So Fast: Deintensification Therapy for Locally Advanced Oral Cavity Cancer

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.01.025

N/A

0DataRank · unranked

1 citations

Steven K. Clinton, Matthew Old, Darrion Mitchell

Data from Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma

(2023)10.1158/1078-0432.c.6532305

N/A

0DataRank · unranked

0 citations

Shuchi Gulati, Sarah Palackdharry, Benjamin H. Hinrichs, Francis P. Worden, Matthew Old +21 more

Data from Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma

(2023)10.1158/1078-0432.c.6532305.v1

N/A

0DataRank · unranked

0 citations

Shuchi Gulati, Sarah Palackdharry, Benjamin H. Hinrichs, Francis P. Worden, Matthew Old +21 more

Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0037

N/A

0DataRank · unranked

10 citations

Kathryn L. Nunes, Pablo Llerena, Anastasia Nikitina, Anastasia Sobol, E. Reilly Scott +30 more